Cao, Tm., Han, Hn., Duan, Yc. et al. Clinical study on long-term treatment of ankylosing spondylitis with integrative medicine., CJIM 8, 36–40 (2002). https://doi.org/10.1007/BF02934616
Tie-mei Cao, Hong-ni Han, Ying-chun Duan, et al. Clinical study on long-term treatment of ankylosing spondylitis with integrative medicine. [J]. Chinese Journal of Integrative Medicine 8(1):36-40(2002)
Cao, Tm., Han, Hn., Duan, Yc. et al. Clinical study on long-term treatment of ankylosing spondylitis with integrative medicine., CJIM 8, 36–40 (2002). https://doi.org/10.1007/BF02934616DOI:
Tie-mei Cao, Hong-ni Han, Ying-chun Duan, et al. Clinical study on long-term treatment of ankylosing spondylitis with integrative medicine. [J]. Chinese Journal of Integrative Medicine 8(1):36-40(2002) DOI: 10.1007/BF02934616.
Clinical study on long-term treatment of ankylosing spondylitis with integrative medicine
摘要
To seek for a new method of integrated Chinese and western medicine in treating ankylosing spondylitis (AS) to control the disease development
shorten the therapeutic course and lower disability rate. Patients of AS enrolled in this study were 106 cases in Group A
who were persistently treated with traditional Chinese medicine and western medicine (TCM-WM) for over 10 months
48 cases in Group B treated with WM and 34 cases in Group C treated with non-steroid anti-inflammatory and analgesic agents. They were followed-up for 2 years. (1) Short-term effect: The markedly effective rate in the 3 groups was 73.58%
47.92% and 5.88% respectively
and the total effective rate was 96.23%
87.50% and 41.18% respectively. The comparison of Group A with Group B and C showed significant difference
the effect in Group A was superior to that in Group B and Group C (x2 = 10.58
P<0.01 and x2 = 67.76
P<0. 01 respectively). (2) Results of 2-year follow-up: the recurrence rate in Group A was 18.37% (9/49)
it was insignificantly different from that in Group B (7/23
30.43%
x2 = 1 . 32
P >0.05)
but significantly different from that in Group C (8/12
66.67%
x2 = H . 19
P < 0.01). Long-term TCM-WM therapy
which combined the advantages of Chinese and western medicine
was a practical method in treating AS with reliable effect
few side-effects
and therefore is worth popularizing.
Abstract
To seek for a new method of integrated Chinese and western medicine in treating ankylosing spondylitis (AS) to control the disease development
shorten the therapeutic course and lower disability rate. Patients of AS enrolled in this study were 106 cases in Group A
who were persistently treated with traditional Chinese medicine and western medicine (TCM-WM) for over 10 months
48 cases in Group B treated with WM and 34 cases in Group C treated with non-steroid anti-inflammatory and analgesic agents. They were followed-up for 2 years. (1) Short-term effect: The markedly effective rate in the 3 groups was 73.58%
47.92% and 5.88% respectively
and the total effective rate was 96.23%
87.50% and 41.18% respectively. The comparison of Group A with Group B and C showed significant difference
the effect in Group A was superior to that in Group B and Group C (x2 = 10.58
P<0.01 and x2 = 67.76
P<0. 01 respectively). (2) Results of 2-year follow-up: the recurrence rate in Group A was 18.37% (9/49)
it was insignificantly different from that in Group B (7/23
30.43%
x2 = 1 . 32
P >0.05)
but significantly different from that in Group C (8/12
66.67%
x2 = H . 19
P < 0.01). Long-term TCM-WM therapy
which combined the advantages of Chinese and western medicine
was a practical method in treating AS with reliable effect
few side-effects
and therefore is worth popularizing.
关键词
ankylosing spondylitisintegrated Chinese and western medicinelong-term therapy
Keywords
ankylosing spondylitisintegrated Chinese and western medicinelong-term therapy
references
Jiang M, Zhu LP, Lin XY. Rheumatology. Beijing: Scientific Press, 1995:952.
Wang ZM. Integrated Chinese and western medicine in treating rheumatic diseases. Tianjin: Tianjin Science & Technology Press, 1989:100–101.
Guo ZC. Medical mathematical statistical methods. 3rd edition. Beijing: People’s Health Publishing House, 1988: 833.
Zeng QY, Xiao ZY. Minutes of symposium on national coordinating group of clinical and epidemiological study of ankylosing spondylitis. Chin J Int Med 1998;37(1):52.
Wang JK, Xing LM, Li JY, et al. Clinical observation on combination therapy in treating ankylosing spondylitis. Chin J Rheum Dis 1998;2(3): 178–179.
The efficacy and safety of Jitongning Capsule (脊痛宁胶囊) in patients with ankylosing spondylitis
Progress on integrated Chinese and Western medicine in the treatment of osteoarthritis
Bushen Qiangji Granule (补肾强脊颗粒) medicated serum inhibits osteogenic differentiation of fibroblasts in ankylosing spondylitis by inhibiting the BMP/Smads signal pathway in vitro
Thoughts and Approaches of Integrated Chinese and Western Medicine for the Treatment of Oligo-astheno-teratozoospermia
Policies on Chinese Medicine in China May Have Enlightenments to Complementary and Alternative Medicine in the World
Related Author
No data
Related Institution
Department of Rheumatology, Chinese PLA General Hospital
Department of Nephrology, First Hospital Affiliated to General Hospital of PLA
Fujian University of Traditional Chinese Medicine
Department of Rheumatology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences
Department of Vaccine Engineering, Beijing Institute of Basic Medical Sciences